Azitra Inc is an early-stage clinical biopharmaceutical company. The Company is focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. Its platform includes a microbial library ... Azitra Inc is an early-stage clinical biopharmaceutical company. The Company is focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. Its platform includes a microbial library comprised of approximately 1,500 bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen its library of strains for drug-like molecules. Its product ATR-12 is a genetically modified strain of S. epidermidis for treating the orphan disease, Netherton syndrome, a chronic and fatal disease of the skin. Its product ATR-04 is a genetically modified strain of S. epidermidis for treating the papulopustular rash. Its product ATR-01 is a human filaggrin protein for treating ichthyosis vulgaris, a chronic, xerotic (abnormally dry), and scaly skin disease. Show more
Azitra, Inc. to Present at the BIO CEO & Investor Conference PR Newswire BRANFORD, Conn., Feb. 3, 2025 BRANFORD, Conn., Feb. 3, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a...
Azitra, Inc. to Present at The Microcap Conference PR Newswire BRANFORD, Conn., Jan. 27, 2025 BRANFORD, Conn., Jan. 27, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage...
Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock PR Newswire BRANFORD, Conn., Jan. 15, 2025 BRANFORD, Conn., Jan. 15, 2025 /PRNewswire/ --Β Azitra, Inc.Β (NYSE American:...
Azitra Announces Proposed Public Offering of Common Stock PR Newswire BRANFORD, Conn., Jan. 14, 2025 BRANFORD, Conn., Jan. 14, 2025 /PRNewswire/ -- Azitra, Inc.Β (NYSE American: AZTR), a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1476 | 58.945686901 | 0.2504 | 0.4099 | 0.2388 | 4329293 | 0.28722383 | CS |
4 | -0.072 | -15.3191489362 | 0.47 | 0.65 | 0.2325 | 4957918 | 0.40941764 | CS |
12 | -0.112 | -21.9607843137 | 0.51 | 0.65 | 0.2325 | 1710410 | 0.4134427 | CS |
26 | -0.1911 | -32.4393142081 | 0.5891 | 0.978 | 0.2325 | 1405934 | 0.5240938 | CS |
52 | -29.602 | -98.6733333333 | 30 | 38.097 | 0.2325 | 1742896 | 3.30463967 | CS |
156 | -127.402 | -99.6885758998 | 127.8 | 155.4 | 0.2325 | 1074214 | 3.96673736 | CS |
260 | -127.402 | -99.6885758998 | 127.8 | 155.4 | 0.2325 | 1074214 | 3.96673736 | CS |
Symbol | Price | Vol. |
---|---|---|
ETHU2x Ether ETF | $ 4.535 (-36.75%) | 165.41M |
SOXLDirexion Daily Semiconductor Bull 3X Shares | $ 25.61 (-5.22%) | 103.91M |
SPXSDirexion Daily S&P 500 Bear 3X Shares New | $ 5.9602 (2.23%) | 91.52M |
TSLZT Rex 2X Inverse Tesla Daily Target ETF | $ 2.54 (10.20%) | 86.35M |
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF | $ 3.77 (5.75%) | 79.38M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.